Table 2. Concomitant in-hospital treatment.
Concomitant in-hospital treatment: | N | Percentage |
---|---|---|
SABA/SAMA aerosol via nebulizer | 165 | 95.4% |
Oral corticosteroids | 163 | 94.2% |
Antibiotics | 133 | 76.9% |
O2-suppletion | 139 | 80.3% |
NIV | 35 | 20.2% |
In-hospital treatment in addition to treatment with HFNC for all included patients. Values shown are the number of patients (N) and percentage (%). SABA: short-acting β-agonist; SAMA: short-acting muscarinic antagonist; NIV: Non-invasive ventilation.